Testing three primate species' attentional biases toward preferred and unpreferred foods: Seeing red or high valued food?
Gillian L ValeJesse G LeinwandPriyanka B JoshiPublished in: Journal of comparative psychology (Washington, D.C. : 1983) (2024)
Animals navigate complex environments that present both hazards and essential resources. The prioritization of perceptual information that is relevant to their next actions, such as accessing or avoiding different resources, poses a potential challenge to animals, one that can impact survival. While animals' attentional biases toward negatively valanced and threatening stimuli have been explored, parallel biases toward differently valued resources remain understudied. Here, we assessed whether three primate species (chimpanzees [ Pan troglodytes ], gorillas [ Gorilla gorilla gorilla ], and Japanese macaques [ Macaca fuscata ]) prioritized their attention to positively valued resources-preferred foods compared to unpreferred foods. We employed a computerized dot probe attentional bias task in which we presented participants with paired images of their preferred and unpreferred foods in randomized locations (left or right). Latencies to touch the "probe" that replaced either image revealed that all three species responded faster to the probe when it replaced the preferred option (χ²(1) = 284.50, SE ² = .03, p < .001). The uniformity of the primates' responses hints that a propensity to prioritize highly preferred items is rooted in these primates' evolutionary past, one that may serve as a mechanism to rapidly detect and locate resources such as highly valued foods. Future research will help disentangle the role that color plays in these biases. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
Keyphrases
- working memory
- quantum dots
- living cells
- deep learning
- emergency department
- genome wide
- gene expression
- dna methylation
- genetic diversity
- double blind
- optical coherence tomography
- healthcare
- clinical trial
- clinical decision support
- social media
- risk assessment
- adverse drug
- phase iii
- randomized controlled trial
- electronic health record